The Uromigos
En podkast av The Uromigos
401 Episoder
-
Episode 21: Treating cancer patients over the next year in the era of COVID-19
Publisert: 15.4.2020 -
Episode 20: Treating GU Cancer Patients with acute COVID-19 Infection
Publisert: 15.4.2020 -
Episode 19: Professor Monty Pal discusses the treatment of non-clear cell renal cancer
Publisert: 15.4.2020 -
Episode 18: COVID-19: Addressing Renal Cancer Patients’ Concerns
Publisert: 6.4.2020 -
Episode 17: Dr. Toni Choueiri discusses cancer trials and meetings during COVID-19
Publisert: 2.4.2020 -
Episode 16: Treatments and Trials for COVID-19
Publisert: 31.3.2020 -
Episode 15: COVID-19 and Bladder Cancer Surgery
Publisert: 28.3.2020 -
Episode 14: A Discussion about Tocilizumab and COVID-19 with Dr. Nick Mark from Seattle
Publisert: 24.3.2020 -
Episode 13: COVID-19 and Hydroxychloroquinine Existing Data and Ongoing Trials
Publisert: 23.3.2020 -
Episode 12: COVID-19 in Cancer Patients - The Seattle Experience
Publisert: 20.3.2020 -
Episode 11: COVID-19 and Immune Checkpoint Inhibitors for the Treatment of Cancer
Publisert: 16.3.2020 -
Episode 10: COVID-19 and Renal Cancer: A Patient's Perspective
Publisert: 16.3.2020 -
Episode 9: COVID-19 and Cancer: An International Perspective
Publisert: 16.3.2020 -
Episode 8: COVID-19 and Cancer Patients
Publisert: 13.3.2020 -
Episode 7: The First Uromigos Prostate Cancer Podcast
Publisert: 27.2.2020 -
Episode 6: Urothelial Cancer Highlights from ASCO GU 2020
Publisert: 26.2.2020 -
Episode 5: Renal Highlights from ASCO GU 2020
Publisert: 24.2.2020 -
Episode 4: Treatment Choices in Front Line Advanced Renal Cancer
Publisert: 11.2.2020 -
Episode 1: Introduction to Uromigos Podcasts
Publisert: 11.2.2020 -
Episode 2: The Current role of IO in Front-line Advanced Urothelial Cancer
Publisert: 11.2.2020
Broadcasting the latest developments in GU cancer Hosted by Brian Rini and Tom Powles Brian Rini MD is a Professor of Cancer Research and Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London
